Fresh Rounds

Aer Therapeutics, Inc. funding

Aer Therapeutics, Inc., a biotechnology company based in Research Triangle Park, NC, filed a Form D with the SEC on August 19, 2026 and reported $3M raised.

Amount raised$3M
Offering size$3M
Filed with the SECAugust 19, 2026
First saleAugust 7, 2026
IndustryBiotechnology
SecuritiesDebt, Options or warrants, Security to be acquired on exercise
LocationResearch Triangle Park, NC
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far7
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in North Carolina